Glooko launches ‘Glooko Office Kiosk’ Package Offering for In-Clinic Diabetes Care

Glooko Office Kiosk is poised to redefine in-clinic diabetes care experience for patients with diabetes and healthcare professionals by bringing insights that drive teachable moments to patient-clinician interactions

Palo Alto, Calif. – September 1, 2015Glooko Inc., today announced the official launch of its “Glooko Office Kiosk” package, which for the first time enables diabetes data from popular blood glucose meters, insulin pumps, and continuous glucose monitors (CGMs) to be synced to an Android tablet and visualized in aggregate on Glooko’s mobile, cloud-based diabetes management platform. By making its technology available in a “Kiosk” style offering, the company is revitalizing the clinical encounter for both diabetes patients and clinicians by adding efficiency and interactivity to the diabetes care process.

The Glooko Office Kiosk enhances each step of diabetes clinical care encounter, which starts with the expectation that a patient’s diabetes device data will be downloaded prior to or at an appointment and be used to drive diabetes care recommendations during the appointment. With the ability to download 40+ diabetes devices and multiple Bluetooth biometric inputs for activity, weight, blood pressure and medications, the Glooko Office Kiosk increases the frequency and quality of data-driven decision support. “Since using Glooko Kiosk in my practice, the time it takes to download data for both Type 1 and Type 2 diabetes patients using a blood glucose meter, insulin pump, and/or CGM has decreased substantially-my practice is more efficient”, said Dr. Michael Greenfield, Glooko CMO.

Not only is downloading made more efficient, but the unified reports that the Glooko Office Kiosk includes enables both the patient and the health care provider to identify trends and insights in data on their mobile phone, the web and via printable reports. During or between office visits, these reports allow focus on trend identification and therapy optimization versus interpreting disparate data points and disjointed reports from a variety of devices.

“Clinical visits are most effective when a patient already has an idea of what is and isn’t working with their therapy regimen,” added Rick Altinger, Glooko CEO. “With Glooko’s data visualizations and pattern identification algorithms, the patient is equipped to ask the right questions before the appointment starts and when it does, the patient and clinician are looking at identical visualizations. This workflow makes each clinical encounter more effective.”

Glooko’s latest innovation has been successfully deployed to diabetes care facilities of all sizes nationwide, from private practices to ACOs, including Scripps Whittier Diabetes Institute, Stanford Hospital, and Cornerstone Health Care. “Glooko Office Kiosk is transitioning me away from the burdensome, proprietary hardware and software I’ve used in the past to intuitive technology that enables both easy diabetes data download and a unified view of my patients’ diabetes data,” said Amy Jasperse, R.Ph., CDE. “My practice is more efficient, and most importantly, Glooko’s insights and reports have enabled me to conduct more meaningful appointments with my diabetes patients.”

Glooko Office Kiosk is compatible with 40+ diabetes devices and growing. Most recently the company showcased its integration with Dexcom CGM data and Insulet’s OmniPod TM wireless insulin delivery system, marking the first CGM and insulin pump integration into the Glooko platform. Glooko’s platform also works with many other industry leaders including Abbott, Johnson and Johnson’s OneTouch® products, Roche, Nipro Diagnostics TM, and Bayer, to mention a few. In the near future Glooko will also integrate with Medtronic ’s MiniMed® products.

For information about the Glooko Office Kiosk, please attend Glooko’s free webinar on the Glooko Office Kiosk on September 8th featuring Dr. Athena Philis-Tsimikas of Scripps Whittier Diabetes Institute. During the webinar, she will discuss how Scripps uses Glooko and the benefits Scripps and their diabetes patients experience using the Glooko platform. Webinar registration is now open.

Glooko Office Kiosk is available for purchase and includes a four-month free subscription trial following an initial hardware fee. Following the free trial Glooko Office Kiosk costs $300/month and can be cancelled at any time. To purchase the Glooko Office Kiosk visit or contact [email protected]

About Glooko
Glooko is the Unified Platform for Diabetes Management and provides an FDA-cleared, HIPAA-compliant Web and Mobile application for diabetes patients and clinicians which improves outcomes and lowers costs. The platform seamlessly unifies data from over 50 of the leading blood glucose meters, insulin pumps, continuous glucose monitors, activity trackers and biometric devices to deliver insights that improve personal and clinical decision support. Glooko’s mobile app enables patients to easily track and proactively manage all aspects of their diabetes care. Glooko’s population management web app and API’s offers diabetes-centric analytics and supplies insightful reports, graphs and pattern-triggered notifications to patients, health systems and payers. The Glooko platform also allows customers and third party developers to create branded modules for Glooko users. Learn more at and follow us at, and .

Glooko PR Contact

Vikram Singh
[email protected]

Press Releases